Bristol Gate Capital Partners Inc. Eli Lilly & CO Transaction History
Bristol Gate Capital Partners Inc.
- $2.05 Billion
- Q1 2025
A detailed history of Bristol Gate Capital Partners Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bristol Gate Capital Partners Inc. holds 118,275 shares of LLY stock, worth $95.6 Million. This represents 4.77% of its overall portfolio holdings.
Number of Shares
118,275Holding current value
$95.6 Million% of portfolio
4.77%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,399Shares Held
807MCall Options Held
9.92MPut Options Held
10.9M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$81.9 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$77.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$64 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$27.8 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $768B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...